Co-Authors
This is a "connection" page, showing publications co-authored by Jacob Nattermann and Christoph Spinner.
Connection Strength
0.116
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
Score: 0.059
-
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)". Infection. 2021 Feb; 49(1):63-73.
Score: 0.057